Medicine & Life Sciences
halichondrin B
100%
eribulin
84%
Breast Neoplasms
33%
Tubulin Modulators
14%
Vinorelbine
11%
Drug Hypersensitivity
11%
taxane
11%
Epirubicin
10%
Ketones
10%
Phase III Clinical Trials
10%
Trastuzumab
10%
Docetaxel
9%
gemcitabine
9%
Peripheral Nervous System Diseases
9%
Head and Neck Neoplasms
8%
Neutropenia
8%
Therapeutics
8%
Drug Interactions
8%
Urinary Bladder Neoplasms
8%
Pancreatic Neoplasms
8%
Sarcoma
8%
Non-Small Cell Lung Carcinoma
7%
Fatigue
7%
Pharmaceutical Preparations
7%
Prostatic Neoplasms
6%
Lung Neoplasms
6%
Clinical Trials
5%
Neoplasms
5%
Physicians
5%
Safety
5%
Survival
4%
Kidney
4%
Incidence
4%
In Vitro Techniques
3%